Smith & Nephew (SNN) EPS (Diluted) Growth (1y) (2010 - 2024)
Smith & Nephew (SNN) EPS (Diluted) Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 95.96% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.19% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.80% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -33.43% |
| Dec 31, 2023 | 8.23% |
| Dec 31, 2022 | -3.60% |
| Dec 31, 2021 | 243.29% |
| Dec 31, 2020 | -131.94% |
| Dec 31, 2019 | 14.47% |
| Dec 31, 2018 | -7.38% |
| Dec 31, 2017 | -16.50% |
| Dec 31, 2016 | 8.76% |
| Dec 31, 2015 | -0.36% |
| Dec 31, 2014 | 25.86% |
| Mar 31, 2014 | -13.07% |
| Dec 31, 2013 | -23.37% |
| Mar 31, 2013 | 162.23% |
| Dec 31, 2012 | 209.23% |
| Jun 30, 2012 | 362.02% |
| Mar 31, 2012 | 16.91% |
| Dec 31, 2011 | 50.76% |
| Sep 30, 2011 | 313,300,609.71% |
| Jun 30, 2011 | 6.24% |